Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inflammatory Breast Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04030507
What this trial is testing

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer+3 more
Brigham and Women's Hospital 214
Testing effectiveness (Phase 2)UnknownNCT03144947
What this trial is testing

Biomarker Study of Immune-mediated Mechanism of Action of Neoadjuvant Trastuzumab in HER2+ Breast Cancer Patients

Who this might be right for
Cancer, Breast
Gruppo Oncologico Italiano di Ricerca Clinica 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT02623972
What this trial is testing

Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
Dana-Farber Cancer Institute 22
Not applicableLooking for participantsNCT06694181
What this trial is testing

Safe and Explainable AI

Who this might be right for
Artifical InteligenceCardiologyBreast Cancer+1 more
Abramson Cancer Center at Penn Medicine 300,000
Testing effectiveness (Phase 2)Study completedNCT01325428
What this trial is testing

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)Study completedNCT00559845
What this trial is testing

Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 56
Very early researchStudy completedNCT05331807
What this trial is testing

Omega-3 and Vitamin D Supplementation in Breast Cancer Women

Who this might be right for
Breast Cancer Female
Universiti Sains Malaysia 88
Not applicableStudy completedNCT07137221
What this trial is testing

Acupuncture And Inflammatory Status In Breast Cancer Patients With Climateric Syndrome.

Who this might be right for
Breast Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 36
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableUnknownNCT05468710
What this trial is testing

Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Ain Shams University 150
Testing effectiveness (Phase 2)Study completedNCT00976989
What this trial is testing

Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 225
Not applicableStudy completedNCT00340158
What this trial is testing

Establishing an Inflammatory Breast Cancer Registry

Who this might be right for
Inflammatory Breast Cancer
National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656
What this trial is testing

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Who this might be right for
EdemaErythemaEstrogen Receptor Negative+6 more
M.D. Anderson Cancer Center 71
Large-scale testing (Phase 3)Study completedNCT00475085
What this trial is testing

Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical Trial

Who this might be right for
Nausea
Joseph Roscoe 1,021
Testing effectiveness (Phase 2)Ended earlyNCT03101748
What this trial is testing

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaLocally Advanced Breast CarcinomaMetastatic Breast Carcinoma+5 more
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT00004925
What this trial is testing

Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT02125344
What this trial is testing

A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)

Who this might be right for
Tubular Breast Cancer Stage IITubular Breast Cancer Stage IIIMucinous Breast Cancer Stage II+4 more
GBG Forschungs GmbH 961
Not applicableStudy completedNCT04418856
What this trial is testing

The Effects of Light Therapy to Treat Cancer-related Side Effects

Who this might be right for
Breast CancerCircadian RhythmsFatigue+4 more
Reykjavik University 260
Large-scale testing (Phase 3)UnknownNCT01093235
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

Who this might be right for
Breast CancerCardiac ToxicityPerioperative/Postoperative Complications
Cambridge University Hospitals NHS Foundation Trust 800
Large-scale testing (Phase 3)UnknownNCT00003680
What this trial is testing

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 300
Next Page